Items where Funder is Kay Kendall Leukaemia Fund.

The University of Leeds

Kaci, F.N., Lepore, A., Mohammad, A. et al. (6 more authors) (2024) Targeting Fatty Acid Oxidation Pathways to Overcome Proteasome Inhibitor Resistance in Multiple Myeloma. In: Updates on Genetics and Epigenetics of Haematological Malignancies: From Knowledge to Applications, 20-22 Nov 2024, Badalona, Barcelona.

Lepore, A orcid.org/0000-0002-2037-673X, Kaci, FN, Bubici, C et al. (1 more author) (2023) An Integrated Methodology to Quantify the Glycolytic Stress in Plasma Cell Myeloma in Response to Cytotoxic Drugs. In: Papa, S and Bubici, C, (eds.) Metabolic Reprogramming: Methods and Protocols. Methods in Molecular Biology, 2675 . Springer , pp. 285-296. ISBN 9781071632468

Kaci, FN, Lepore, A orcid.org/0000-0002-2037-673X, Papa, S orcid.org/0000-0002-8369-6538 et al. (1 more author) (2023) Screening Kinase-Dependent Phosphorylation of Key Metabolic Reprogramming Regulators. In: Papa, S and Bubici, C, (eds.) Metabolic Reprogramming Methods and Protocols. Methods in Molecular Biology, 2675 . Springer , pp. 205-218. ISBN 978-1-0716-3246-8

Zacharchenko, T and Wright, S orcid.org/0000-0002-3509-7506 (2021) Functionalization of the BCL6 BTB domain into a noncovalent crystallization chaperone. IUCrJ, 8 (2). pp. 154-160. ISSN 2052-2525

Worrillow, L, Baskaran, P, Care, MA et al. (9 more authors) (2016) An ultra-deep sequencing strategy to detect sub-clonal TP53 mutations in presentation chronic lymphocytic leukemia cases using multiple polymerases. Oncogene, 35 (40). pp. 5328-5336. ISSN 0950-9232

Müller, LME, Holmes, M, Michael, JL et al. (20 more authors) (2019) Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21. Journal for ImmunoTherapy of Cancer, 7. 164. ISSN 2051-1426

Müller, LME, Migneco, G, Scott, GB et al. (17 more authors) (2021) Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow niche. Journal for ImmunoTherapy of Cancer, 9 (3). e001803. ISSN 2051-1426